Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14850
Abstract: AIM To evaluate pharmacokinetic equivalence and preliminary safety of the adalimumab biosimilar CT-P17 administered via autoinjector (CT-P17 AI) or prefilled syringe (CT-P17 PFS) in healthy subjects. METHODS This phase I, open-label study (ClinicalTrials.gov: NCT04295356) randomised… read more here.
Keywords: p17 pfs; equivalence; p17 p17; pharmacokinetic equivalence ... See more keywords
Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Korean Medical Science"
DOI: 10.3346/jkms.2018.33.e258
Abstract: Background In type 2 diabetes mellitus therapy, fixed-dose combination (FDC) can offer not only benefits in glucose control via the combined use of agents, but also increase patient compliance. The aim of this study was… read more here.
Keywords: gemigliptin metformin; gemigliptin; tablet gemigliptin; pharmacokinetic equivalence ... See more keywords